Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs – biological activities and SAR studies-Reference-Cited by-同舟云学术

Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs – biological activities and SAR studies

Published:2021 Issue:20 Volume:11 Page:12254-12287
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Faheem ¹²³⁴⁵^ORCID,Karan Kumar Banoth¹²³⁴⁵^ORCID,Chandra Sekhar Kondapalli Venkata Gowri⁶³⁷⁵,Chander Subhash⁸⁹¹⁰⁵,Kunjiappan Selvaraj¹¹¹²¹³⁵^ORCID,Murugesan Sankaranarayanan¹²³⁴⁵^ORCID

Affiliation:

1. Medicinal Chemistry Research Laboratory

2. Department of Pharmacy

3. Birla Institute of Technology and Science-Pilani

4. Pilani-333031

5. India

6. Department of Chemistry

7. Hyderabad

8. Amity Institute of Phytomedicine and Phytochemistry

9. Amity University Uttar Pradesh

10. Noida-201313

11. Department of Biotechnology

12. Kalasalingam Academy of Research and Education

13. Krishnankoil-626126

Abstract

This review provides critical insights into the biological activities and Structure–Activity Relationship (SAR) studies of tetrahydroisoquinoline (THIQ) analogs.

Funder

Department of Biotechnology, Ministry of Science and Technology, India

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/RA/D1RA01480C

Reference110 articles.

1. Chemistry and Biology of the Tetrahydroisoquinoline Antitumor Antibiotics

2. Synthesis, antibacterial activity and QSAR studies of 1,2-disubstituted-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines

3. Design, synthesis, and antifungal activities in vitro of novel tetrahydroisoquinoline compounds based on the structure of lanosterol 14α-demethylase (CYP51) of fungi